Write to members of Indian governement and European Commission to save affordable medicines and access to life-saving treatments in Africa, Asia and Latin America !
Positive Living HIV (PLHIV) organisations in Malaysia yesterday expressed concern over the potential negative impact on HIV medication of Free Trade Agreements (FTAs) which the government is currently negotiating with the United States and the European Commission (EC).
The Korea-EU FTA must be dismantled. And the lives of patients in over 120 countries are on the line regarding the India-EU FTA. What will devastate the Pharmacy of the World must also be stopped.
People in Asia living with HIV and who depend on affordable generic AIDS medicines to stay alive have impressed upon the Indian government to stand strong against European Union demands on the sensitive Intellectual Property (IP) chapter in ongoing Free Trade Agreement (FTA) negotiations.
Thousands of people with HIV and cancer marched through the streets of India's capital Wednesday to protest a planned trade deal with the European Union that they claim would restrict access to affordable medicines.
The EU's proposed trade agreement is riddled with intellectual property provisions that would harm India's 2005 Patent Act and block public-interest rulings such as the Aluvia decision.
"It’s like an ant fighting an elephant. We are one of the weakest and poorest groups and they (the EU and the pharmaceutical industry) are among the richest and strongest."
Public Citizen and Forum on Democracy and Trade met with US Trade Representative staff on January 3 to be briefed on the Obama administration’s negotiation of the TPP with respect to the planned IP chapter and the rumored chapter on pharmaceutical reimbursement programs.
Kenyan activists have written to the European Union and the Kenya Government, protesting what they term damaging trade agreements such as the European Union-India Free Trade Agreement and the Anti-Counterfeiting Trade Agreement. They say the pacts would damage the fight against Aids.